Group 1 - The Hong Kong Stock Connect Innovative Drug ETF (Southern, 159297) experienced a decline of 1.24% on February 5, with a trading volume of 48.6647 million yuan [1] - The fund's shares increased by 2 million, bringing the total shares to 2.023 billion, with a total increase of 161 million shares over the last 20 trading days [1] - The latest net asset value is calculated at 1.633 billion yuan [1] Group 2 - The performance benchmark for the Hong Kong Stock Connect Innovative Drug ETF is the National Index for Hong Kong Stock Connect Innovative Drugs (adjusted for valuation exchange rates) [1] - The fund is managed by Southern Fund Management Co., Ltd., with fund managers Zhang Qisi and Ye Zhenan [1] - Since its establishment on September 12, 2025, the fund has reported a return of -19.30%, with a return of -2.93% over the past month [1]
2月5日港股通创新药ETF南方（159297）份额增加200.00万份
Xin Lang Cai Jing·2026-02-06 01:16